Scientific Program
1. Special Guest Lecture:
Tuesday, September 13,13:30-14:30Concord ABC
Chairpersons: Akira Iritani (Japan)
13:30-14:30 | Induction of pluripotency by defined factors | Shinya Yamanaka (Japan) |
2. Opening Ceremony, Lecture and Welcome Reception:
Opening Ceremony:
Saturday, September 10,18:30-19:30Eminence Hall, 5F
18:30-19:00 19:00-19:30 |
Opening Ceremony Opening Lecture |
A tribute to Robert Edwards - the pioneer of human IVF |
Victor Gomel (Canada) |
Welcome Reception:
Saturday, September 10,19:30-21:30Concord ABC, 5F
3. Plenary Sessions:
Sunday, September 11,8:30-10:00Concord ABC
Chairperson: Victor Gomel (Canada)
8:30-8:50 | Plenary -1 (1) | Advances in natural and mild stimulation cycle IVF - progress over the last 15 years | Osamu Kato (Japan) |
Chairperson: Victor Gomel (Canada)
8:50-9:00 | Plenary -1 (2) | Clomid® ovarian stimulation for IVF and frozen ET |
John Zhang (USA) |
Chairperson: Sherman Silber (Japan)
9:00-9:00 | Plenary -2 | Non-invasive assessment of embryo quality | Zsolt Peter Nagy (USA) |
Chairperson: Takahide Mori (Japan)
9:30-10:00 |
Plenary -3 |
The prospect of embryonic stem cell research | Shin Yong Moon (Korea) |
Monday, September 12,8:30-10:00Concord ABC
Chairperson: Atsushi Tanaka (Japan)
8:30-9:00 | Plenary -4 | Pre-implantation genetic diagnosis: an update | Alan Handyside (UK) |
Chairperson: Chii-Ruey Tzeng (Taiwan)
9:00-9:30 | Plenary -5 | Preservation of fertility | Sherman Silber (USA) |
Chairperson: Shuetsu Suzuki (Japan)
9:30-10:00 | Plenary -6 | The role of reproductive surgery in the era of IVF&ART | Victor Gomel (Canada) |
Tuesday, September 13,8:30-10:00Concord ABC
Chairperson: Yoon-Seok Chang (Korea)
8:30-9:00 | Plenary -7 | Recent advance of controlled ovarian stimulation | Klaus Diedrich (Germany) |
Chairperson: Hiroshi Okada (Japan)
9:00-9:30 | Plenary -8 | Tending to male factor couples | Gianpiero D. Palermo (USA) |
Chairperson: Yoshiharu Morimoto (Japan)
9:30-10:00 | Plenary -9 |
IVM for fertility treatment and preservation of fertility |
Seang Lin Tan (Canada) |
4. Pre-Congress Workshops:
1) Vitrification
Saturday, September 10,9:00-12:00Hana A
Chairpersons: Stanley Leibo (USA), Masashige Kuwayama (Japan)
(1) Lectures1. Basic science of vitrification | Stanley Leibo (USA) |
2. Ovarian reserving (basic research) | Noriko Kagawa (Japan) |
3. Ovary Transplant: Ovary allotransplantation between non-hemozygeous sisters: Success and failure, an immunologic puzzle | Sherman Silber (USA) |
4. The Cryotop® method | Masashige Kuwayama (Japan) |
2) Pre-implantation genetic diagnosis (PGD)
Saturday, September 10,14:00-17:00Hana A
Chairpersons: Naoki Aoyama (Japan), Ilan Tur-Kaspa (USA)
(1) Lectures1. Overview | Kou Sueoka (Japan) |
2. Whole genome amplification is a new basic technology for next-generation preimplantation genetic diagnosis on mendelian inheritance disease | Suguru Sato (Japan) |
3. To PGD or not to PGD? How many oocytes are needed to start PGD with? | Ilan Tur-Kaspa (USA) |
4. Efficient techniques of PGD for recurrent pregnancy loss (Live) | Naoki Aoyama (Japan) |
5. Concurrent Symposia:
C-1 Management of PCO patients (1)
Sunday, September 11,10:30-11:50Concord A
Chairpersons: Timur Gürgan (Turkey), Makio Shozu (Japan)
10:30-10:50 | 1. Androgenic spectrum concept of PCO morphogenesis | Takahide Mori (Japan) |
10:50-11:10 | 2. Do phenotypic differences in PCOS affect fertility treatment and outcomes? | Rogerio A. Lobo (USA) |
11:10-11:30 | 3. Laser assisted ICSI for oocytes matured in vitro from PCO patients | Muchsin Jaffar (Indonesia) |
11:30-11:50 | 4. The use of GnRH antagonist in the controlled ovarian stimulation for IVF in PCOS patients | Khaled Mahmoud (Tunisia) |
C-2 Management of PCO Patients (2)
Sunday, September 11,13:20-15:00Concord A
Chairpersons: Rogerio A. Lobo (USA), Khaled Mahmoud (Tunisia)
13:20-13:40 | 1. Polycystic ovary syndrome is associated with metabolic abnormalities in the purine mononucleotide pathway and tricarboxylic acid cycle | Makio Shozu (Japan) |
13:40-14:00 | 2. How to get pregnancy in women with PCOS | Chii-Ruey Tzeng (Taiwan) |
14:00-14:20 | 3. ART Management in PCO | Toshiro Kubota (Japan) |
14:20-14:40 | 4. PCO and ovarian drilling | Timur Gürgan (Turkey) |
14:40-15:00 | 5. PCO and transvaginal hydrolaparoscopic ovarian drilling (THLOD) | Hiroaki Shibahara (Japan) |
C-3 Controlled ovarian stimulation (1)
Sunday, September 11,15:20-16:40Concord A
Chairpersons: Bruno Lunenfeld (Israel),TBA (Japan)
15:20-15:40 | 1. Available tools to personalize ovarian stimulation - Dose prediction/protocol selection |
Bruno Lunenfeld (Israel) |
15:40-16:00 | 2. Advances in ultrasound monitoring of IVF cycles by automated volume measurment | Baris Ata (Canada) |
16:00-16:20 | 3. Volmetric measurements of the follicular development | Maximilian Murtinger (Austria) |
16:20-16:40 | 4. Ovarian stimulation and endometrial receptivity | Pak-Chung Ho (Hong Kong) |
C-3 Controlled ovarian stimulation (2)
Sunday, September 11,16:40-18:00Concord A
Chairpersons: Svend Lindenberg (Denmark), Minoru Irahara (Japan)
16:40-17:00 | 5. Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer | John Zhang (USA) |
17:00-17:20 | 6. Poor responder patients undergoing IVF treatment | Svend Lindenberg (Denmark) |
17:20-17:40 | 7. Prediction and prevention of the ovarian hyperstimulation syndrome (OHSS) - an evidence-based approach | Hassan Sallam (Egypt) |
17:40-18:00 | 8. What should we prefer for IVF - the agonist or antagonist? | Zion Ben-Rafael (Israel) |
C-4 Treatment of benign tumor prior to IVF-ET (1)
Sunday, September 11,10:30-11:50Concord B
Chairpersons: Zion Ben-Rafael (Israel), Hassan Sallam (Egypt)
10:30-10:50 | 1. Evidence-based management of endometriosis-associated infertility | Hassan Sallam (Egypt) |
10:50-11:10 | 2. Surgery of endometriosis in infertility: state of the art ! | Issam Lebbi (Tunisia) |
11:10-11:30 | 3. Surgical management of recurrent endometrioma: prior to IVF or not | Hiroshi Nabeshima (Japan) |
11:30-11:50 | 4. Management of hydrosalpinges prior to IVF-ET | Victor Gomel (Canada) |
C-5 Treatment of uterine myoma or adenomyosis prior to IVF-ET (2)
Sunday, September 11,13:20-15:00Concord B
Chairpersons: Victor Gomel (Canada), Issam Lebbi (Tunisia)
13:20-13:40 | 1. Surgery of intra-mural leiomyomas in infertile patients | Jean-Bernard Dubuisson (Switzerland) |
13:40-14:00 | 2. Myomectomy during pregnancy | Yuji Hiramatsu (Japan) |
14:00-14:20 | 3. Uterine fibroids and IVF- what is the controversy? | Zion Ben-Rafael (Israel) |
14:20-14:40 | 4. A novel operative treatment of severe adenomyosis prior to embryo transfer | Hisao Osada (Japan) |
14:40-15:00 | 5. Different surgical approaches for myomectomy and for adenomyosis | Michael DeRosa (USA) |
C-6 Oncofertility - fertility preservation in women with malignant disease (1)
Sunday, September 11,15:20-16:40Concord B
Chairpersons: Claus Yding Andersen (Denmark), Takeshi Maruo (Japan)
15:20-15:40 | 1. The oncofertility: consequences of a previous oncological treatments and possibilities |
Rufino Garcia-Otero Reina (Spain) |
15:40-16:00 | 2. Fertility Sparing in Stage Ia2 to Ib1-Cervix Carcinoma | Werner Lichtenegger (Germany) |
16:00-16:20 | 3. Abdominal radical trachelectomy in our experience of 126 cases | Takuma Fujii (Japan) |
16:20-16:40 | 4. Laparoscopic radical trachelectomy | Masaaki Ando (Japan) |
C-7 Oncofertility - fertility preservation in women with malignant disease (2)
Sunday, September 11,16:40-18:00Concord B
Chairpersons: Klaus Diedrich (Germany), Kazunori Ochiai (Japan)
16:40-17:00 | 1. Cryopreservation of human oocyte for cancer patients in Japan | Shokichi Teramoto (Japan) |
17:00-17:20 | 2. Cryopreservation of human ovarian tissue, clinical data and scientific considerations | Claus Yding Andersen (Denmark) |
17:20-17:40 | 3. Conservative therapy for borderline ovarian cancer | Liong Tulusan (Germany) |
17:40-18:00 | 4. Infertility, ovulation induction treatments and the incidence of breast, ovarian and endometrial cancers - thirty years of follow up | Bruno Lunenfeld (Israel) |
C-8 ART-cryopreservation: Is oocyte cryopreservation a revolution in IVF?
Sunday, September 11,10:30-11:50Concord C
Chairpersons: Stanley Leibo (USA), Masashige Kuwayama (Japan)
10:30-10:50 | 1. Highly efficient and safe vitrification using hydroxypropyl cellulose as a macromolecular supplement for cryopreservation of oocytes and blastocysts | Luis Arturo Ruvalcaba Castellón (Mexico) |
10:50-11:10 | 2. Role and possibility of vitrification in human oocyte | Masashige Kuwayama (Japan) |
11:10-11:30 | 3. Blastulation and pregnancy rates after vitrified human zygote culture for 4 days: Preliminary results | Safaa Al Hasani (Germany) |
11:30-11:50 | 4. Cryopreservation in human ART | Stanley Leibo (USA) |
C-9 Children follow up in ART (1)
Sunday, September 11,13:20-14:40Concord C
Chairpersons: Fethi Zhioua (Tunisia), Osamu Ishihara (Japan)
13:20-13:40 | 1. Evaluate the IVF success rates of accumulated pregnancy rates per oocyte retrieval |
Jia-Yin Liu (China) |
13:40-14:00 | 2. Genetics and health of children born from cryopreserved oocytes |
Ilan Tur-Kaspa (USA) |
14:00-14:20 | 3. What has happened on epigenetics in ART children? | Yukiko Katagiri (Japan) |
14:20-14:40 | 4. Pregnancy and child outcome after assisted reproductive technologies | Dov Feldberg (Israel) |
C-10 Children follow up in ART (2)
Sunday, September 11,15:00-16:20Concord C
Chairpersons: Hideaki Kanzaki (Japan), Dov Feldberg (Israel)
15:00-15:20 | 1. Just Twins? Perinatal data from multiple pregnancies | Peter Brockerhoff (Germany) |
15:20-15:40 | 2. Perinatal outcomes of ART pregnancies | Fethi Zhioua (Tunisia) |
15:40-16:00 | 3. Outcome of IVM babies | Ri-Cheng Chian (Canada) |
16:00-16:20 | 4. Perinatal outcome of vitrified human blastocysts in 11 years experience (5434 attempted cycles) including the rate of monozygotic twinning (MZT) | Tetsunori Mukaida (Japan) |
C-11 Laboratory advances in IVF (1)
Sunday, September 11,16:20-17:40Concord C
Chairpersons: Pierre Vanderzwalmen (Belgium), Gábor Vajta (Australia)
16:20-16:40 | 1. Novel embryo culturing and monitoring systems | Artur Bernard (Hungary) |
16:40-17:00 | 2. Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF |
Guoning Huang (China) |
17:00-17:20 | 3. An integral view on therapeutic options and lab-techniques for individualized therapy in IVF | Nicolas Zech (Austria) |
17:20-17:40 | 4. How to manage the modern IVF laboratory | Zsolt Peter Nagy (USA) |
C-12 Laboratory advances in IVF (2)
Sunday, September 11,13:20-14:40Hana A
Chairpersons: Yoshihiko Hosoi (Japan), Zsolt Peter Nagy (USA)
13:20-13:40 | 1. Chemical substances exposure on IVF-ET environment | Tsunehisa Makino (Japan) |
13:40-14:00 | 2. Recent insights into the oocyte maturation in ART | Tae-Ki Yoon (Korea) |
14:00-14:20 | 3. Use of high concentrations of cryoprotectants: is it a justified argument to prefer slow freezing instead of vitrification? | Pierre Vanderzwalmen (Belgium) |
14:20-14:40 | 4. Embryo culture: Can we perform better than Nature? | Gábor Vajta (Australia) |
C-13 Controlled ovarian stimulation (3)
Monday, September 12,10:30-11:50Concord A
Chairpersons: Herbert Zech (Austria), Osamu Tsutsumi (Japan)
10:30-10:50 | 1. Superovulation/IUI - An Alternative to IVF | Bill Yee (USA) |
10:50-11:10 | 2. Treatment of patients with high FSH with delayed stimulation using low dose gonadotrophins | Milton Leong (Hong Kong) |
11:10-11:30 | 3. Use of hCG in ovarian stimulation | Johan Smitz (Belgium) |
11:30-11:50 | 4. Follicle stimulation by transdermal application of FSH | Herbert Zech (Austria) |
C-14 Advances in basic research and laboratory techniques in IVM (1)
Monday, September 12,13:20-14:20Concord A
Chairpersons: Yoshiharu Morimoto (Japan), Ri-Cheng Chian (Canada)
13:20-13:40 | 1. IVM: learning from IVM ? | Nelly A. Frydman (France) |
13:40-14:00 | 2. Quality evaluation of human & mouse IVM embryo and epigenetic evaluation of human born IVM babies | Hiroaki Yoshida (Japan) |
13:20-13:40 | 3. Lessons from the mouse follicle culture and in vitro maturation models | Johan Smitz (Belgium) |
C-14 Advances in basic research and laboratory techniques in IVM (2)
Monday, September 12,14:20-15:20Concord A
Chairpersons: Jie Qiao (China), Hiroaki Yoshida (Japan)
14:20-14:40 | 4. Laboratory aspect of natural cycle IVF/ IVM treatment | Ri-Cheng Chian (Canada) |
14:40-15:00 | 5. Cytoplasmic maturation and mitochondrial activity in human IVM | Yoshiharu Morimoto (Japan) |
15:00-15:20 | 6. Correct embryo selection improves embryo implantation rates in IVM cycles | Hai Ying Chen (Canada) |
C-15 Clinical outcomes; toward a more successful IVM
Monday, September 12,15:40-17:20Concord A
Chairpersons: Johan Smitz (Belgium), Aisaku Fukuda (Japan)
15:40-16:00 | 1. IVM application in PCOS patients | Jie Qiao (China) |
16:00-16:20 | 2. Oocyte maturation from tiny follicles in human ovarian tissues | Shu Hashimoto (Japan) |
16:20-16:40 | 3. Natural cycle combined with IVM | Jin-Ho Lim (Korea) |
16:40-17:00 | 4. The effective approach for IVM using Metformin | Aisaku Fukuda (Japan) |
17:00-17:20 | 5. Clinical implications of IVM | Svend Lindenberg (Denmark) |
C-16 Embryo development and competency from activation to implantation
Monday, September 12,10:30-12:10Concord B
Chairpersons: Jin-Ho Lim (Korea), Atsushi Azumaguchi (Japan)
10:30-10:50 | 1. Morphological aspect | Nelly A. Frydman (France) |
10:50-11:10 | 2. Early embryo development: what's critical | Moncef Benkhalifa (France) |
11:10-11:30 | 3. Implantation window | Atsushi Azumaguchi (Japan) |
11:30-11:50 | 4. Luteal phase support | Svend Lindenberg (Denmark) |
11:50-12:10 | 5. Predictors of IVF outcome with a particular interest in the mount of gonadotropin administered | Peter Kovacs (Hungary) |
C-17 ART-Gamete manipulation
Monday, September 12,13:20-14:20Concord B
Chairpersons: Moncef Benkhalifa (France), Atsushi Tanaka (Japan)
13:20-13:40 | 1. Whole ooplasmic replacement in Germinal Vesicle oocytes | Akiko Yabuuchi (Japan) |
13:40-14:00 | 2. Dynamic genome function and chromosomes abnormalities | Moncef Benkhalifa (France) |
14:00-14:20 | 3. A novel trial of nuclear transfer for repairing an aged oocyte | Atsushi Tanaka (Japan) |
C-18 Update on male infertility IMSI/ ICSI/ MD-TESE/ PGD
Monday, September 12,14:20-15:20Concord B
Chairpersons: Sherman Silber (USA), Hiroshi Okada (Japan)
14:20-14:40 | 1. Male infertility | Sherman Silber (USA) |
14:40-15:00 | 2. Microdissection Testicular Sperm Extraction(MD-TESE) | Atsumi Yoshida (Japan) |
15:00-15:20 | 3. IMSI, already 8 years in ART practice. Where do we stand? | Pierre Vanderzwalmen (Belgium) |
C-19 AMH: Is it essential for assessing ovarian reserve
Monday, September 12,10:30-11:50Concord C
Chairpersons: Bunpei Ishizuka (Japan), Hsin-Fu Chen (Taiwan)
10:30-10:50 | 1. Clinical application of AMH in the reproductive medicine | Yoshimasa Asada (Japan) |
10:50-11:10 | 2. Chronological aging VS biological aging: AMH as an early marker of biological aging | Budi Wiweko (Indonesia) |
11:10-11:30 | 3. POF and AMH | Bunpei Ishizuka (Japan) |
11:30-11:50 | 4. Dynamic serum AMH levels and AMH-related gene expression in human ovarian follicles | Hsin-Fu Chen (Taiwan) |
C-20 The role of ART in international development (1)
Monday, September 12,13:20-14:20Concord C
Chairpersons: Willem Ombelet (Belgium), Sheryl Vanderpoel (Switzerland)
13:20-13:40 | 1. Implantation of the fertility assistance program after the Wenchuan earthquake in China | Shangwei Li (China) |
13:40-14:00 | 2. Cross-border cryo-shipping of vitrified embryos (CCVE): the newest ART success story | Gautam Allahbadia (India) |
14:00-14:20 | 3. Cross-border reproductive care: exploitation or opportunity in the global quest for a baby? | Daniel S. Seidman (Israel) |
14:20-14:40 | 4. Oocyte donors: prevalence of genetic, infectious diseases and others | Oriol Coll (Spain) |
C-20 The role of ART in international development (2)
Monday, September 12,14:20-15:20Concord C
Chairpersons: Daniel Seidman (Israel), Tetsunori Mukaida (Japan)
14:40-15:00 | 5. Vouchers for health: A demand side output-based aid approach to reproductive health services. A model to pay for infertility services? | Claus Peter Janisch (Germany) |
15:00-15:20 | 6. Global challenges and perspectives | Sheryl Vanderpoel (Switzerland) |
15:20-15:40 | 7. Affordable IVF: low cost IVF - The Arusha project | Willem Ombelet (Belgium) |
C-21 Repeated implantation failure: how to improve implantation in ART
Tuesday, September 13,10:30-11:50Concord A
Chairpersons: Kouichi Takakuwa (Japan), Yael Gonen (Israel)
10:30-10:50 | 1. How to improve implantation in ART: novel approaches | Yael Gonen (Israel) |
10:50-11:10 | 2. Studies on the efficacy of immunotherapy using paternal mononuclear cells for patients with infertility | Kouichi Takakuwa (Japan) |
11:10-11:30 | 3. Improvement of implantation rates using autologous peripheral blood mononuclear cells | Hiroshi Fujiwara (Japan) |
11:30-11:50 | 4. Prevention of infertility in patients for the antiphospholipid syndrome and deficiencies of natural anticoagulants | Moritoshi Seki (Japan) |
C-22 Pre-implantation genetic screening: an update
Tuesday, September 13,10:30-11:50Concord B
Chairpersons: Hidekazu Saito (Japan), Jiaen Liu (China)
10:30-10:50 | 1. PGD for recurrent pregnancy loss | Atsushi Tanaka (Japan) |
10:50-11:10 | 2. Polar body analysis in clinical practice as compared to pre-embryo morphology for selection of the best for transfer | Wilfried Feichtinger (Austria) |
11:10-11:30 | 3. PGD outcome and alternatives for single gene disorder | Kou Sueoka (Japan) |
11:30-11:50 | 4. Preimplantation genetic diagnosis for aneuploidy using whole genome amplification and microarray comparative genomic hybridization | Alan Handyside (UK) |
C-23 Stem cell and fertility preservation: Where are we at with stem cells?
Tuesday, September 13,10:30-12:10Concord C
Chairpersons: Kwang Yul Cha (Korea), Oktay Kadayifci (Turkey)
10:30-10:50 | 1. Human ES cell and iPS cell derivation: Clinical applications and biological characterization | Hidenori Akutsu (Japan) |
10:50-11:10 | 2. Pluripotent stem cell as a source of germ cells - Is it still a fiction? | Anis Feki (Switzerland) |
11:10-11:30 | 3. Development of pluripotent stem cells to female germ cells | Hsin-Fu Chen (Taiwan) |
11:30-11:50 | 4. Testicular stem cells as sources of fertility preservation and cell therapy | Kwang Yul Cha (Korea) |
11:50-12:10 | 5. In vitro production of functional sperm in cultured neonatal mouse testes | Takehiko Ogawa (Japan) |
6. STGO Session (Tunisian Society of Gynecology and Obstetrics)
(Coordinators: Khaled Mahmoud, Fethi Zhioua, Issam Lebbi)
Challenging issues in ART (1)
Monday, September 12,16:00-17:00Concord C
Chairpersons: Hedi Khairi, Anis Feki, Said Lazrak
16:00-16:20 | 1. How to manage hyper-response to COS in IVF | Youssef Boutaleb (Morocco) |
16:20-16:40 | 2. How to manage poor-responders? | René Frydman (France) |
16:40-17:00 | 3. The thin endometrium in ART: What to do? | Amina Oumziane (Algeria) |
Challenging issues in ART (2)
Monday, September 12,17:00-18:00Concord C
Chairpersons: Mahmoud Kharouf, Moise Fiadjoe, Nabil Ben Zineb
17:00-17:20 | 1. How to treat the female causes of repeated implantation failure? | Khaled Terras (Tunisia) |
17:20-17:40 | 2. How to manage sperm investigation after ICSI Failure? | Moncef Benkhalifa (France) |
17:40-18:00 | 3. How to improve laboratory procedures to enhance implantation? | Merdassi Ghaya (Tunisia) |
7. ISF Session by the Israeli Society of Fertility
Monday, September 12,15:40-17:40Concord B
(Coordinator: Daniel Seidman)
Chairpersons: Arye Hurwitz, Martha Dirnfeld
15:40-16:00 | 1. Fertility enhancement in patients with adenomyosis using MRI guided HIFUS | Yaron Rabinovici (Israel) |
16:00-16:20 | 2. Gonadotropin-releasing hormone agonist trigger: the way to eliminate OHSS | Arye Hurwitz (Israel) |
16:20-16:40 | 3. From endometrial injury to IMSI: New approaches for repeated IVF failure | Martha Dirnfeld (Israel) |
16:40-17:00 | 4. High ART success rates when financial constraints are completely lifted | Daniel Seidman (Israel) |
17:00-17:20 | 5. Autologous transplantation of very thin ovarian fragments which preserve the ovary's main cortex structure lead to successful pregnancy | Ariel Revel (Israel) |
17:20-17:40 | 6. How should we consult candidates for fertility preservation due to a malignant disease regarding their expected ovarian response to COH? | Shevach Friedler (Israel) |
8. APART Session: MSCs - From basic research to clinical applications
Monday, September 12,13:20-15:00Hana A
Chairpersons: Yuji Takehara (Japan), Byung-Rok Do (Korea)
13:20-13:40 | 1. Clinical efficacy of adipose MSCs in human | Byung-Rok Do (Korea) |
13:40-14:00 | 2. Human lipoaspiration | Ken Nakama (Japan) |
14:00-14:20 | 3. Vitrification of adipose MSCs | Noriko Kagawa (Japan) |
14:20-14:40 | 4. Preparation of adipose-derived stem cells | Rie Yamadera (Japan) |
14:40-15:00 | 5. Discussion about clinical applications of adipose MSCs | Yuji Takehara (Japan) |
9. Oral communications
10. Poster Sessions
Poster viewing time (Hana B C D)
Sunday, September 11,10:00-10:30, 13:00-13:20Hana B C D
Monday, September 12,10:00-10:30, 13:00-13:20Hana B C D
11. Luncheon Seminars
Luncheon Seminar 1Sunday, September 11,12:00-13:00Concord A
Chairperson: Takafumi Utsunomiya (Japan)
12:00-13:00 | GnRH antagonists in ovarian stimulation for IVF and ICSI from practical perspective | Atsushi Tanaka (Japan) |
Luncheon Seminar 2Sunday, September 11,12:00-13:00Concord B
Chairperson: Osamu Ishihara (Japan)
12:00-13:00 | Clinical aspects of GnRH analogue use in Assisted reproduction | Naoaki Kuji (Japan) |
Luncheon Seminar 3Sunday, September 11,12:00-13:00Concord C
Chairperson: Fumihito Aono
12:00-12:20 | 1. TBA | Teruhiko Wakayama (Japan) |
12:20-12:40 | 2. TBA | Hiroshi Morita (Japan) |
12:40-13:00 | 3. TBA | Akiko Yabuuchi (Japan) |
Luncheon Seminar 4Monday, September 12,12:00-13:00Concord A
Chairperson: Yoshiharu Morimoto (Japan)
12:00-13:00 | The role of AMH in female reproduction | Budi Wiweko (Indonesia) |
Luncheon Seminar 5Monday, September 12,12:00-13:00Concord C
Chairperson: Yuji Takehara
12:00-13:00 | Fertility tourism in the U.S. | John Zhang (USA) |